- ►annals.org SL Morgan, JE Baggott, WH Vaughn, JS … - Annals of internal …, 1994 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Objective: To determine the effect
of two different weekly doses of folic acid on the toxicity and efficacy of low-dose ... Cited by 204 - Related articles - BL Direct - All 7 versions
SL Morgan, JE Baggott, WH Vaughn, PK Young, … - Arthritis …, 1990 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: The effect of folic acid
supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid
arthritis. Author: Morgan, SL : Baggott, JE : Vaughn, WH : Young ... Cited by 165 - Related articles - Cached - All 3 versions
JB Shiroky, C Neville, JM Esdaile, D Choquette … - Arthritis Care & … - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 69 - Related articles - BL Direct - All 4 versions
AE Van Ede, RF Laan, MJ Rood, TW Huizinga, … - Arthritis Care & … - interscience.wiley.com Patients with active RA (n = 434) were randomly assigned to receive MTX plus either
placebo, folic acid (1 mg/day), or folinic acid (2.5 mg/week). The initial MTX dosage was 7.5
mg/week; dosage increases were allowed up to a maximum of 25 mg/week for insufficient ... Cited by 156 - Related articles - BL Direct - All 6 versions
JM Kremer, GS Alarcón, RW Lightfoot Jr, RF … - Arthritis Care & … - interscience.wiley.com Methotrexate (MTX) has become an important drug in the treatment of rheumatoid arthritis
(RA). The American College of Rheumatology convened a committee to assess the risks of development
of clinically significant liver disease (CSLD) during MTX treatment, to evaluate the risk ... Cited by 346 - Related articles - BL Direct - All 5 versions
- ►nih.gov [PDF] DA Joyce, RK Will, DM Hoffman, B Laing, SJ … - British Medical …, 1991 - ard.bmj.com Abstract A double blind, placebo controlled trial examined the effects of folinic acid on the efficacy
and toxicity of methotrexate in27 patients with rheumatoid arthritis. Clinical and laboratory indices
of disease activity worsened significantly in the 13 patients treated with folinic acid after ... Cited by 47 - Related articles - All 8 versions
ME Weinblatt, AL Maier, JS Coblyn - J Rheumatol, 1993 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: Low dose leucovorin does not interfere with
the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial.
Author: Weinblatt, ME : Maier, AL : Coblyn, JS Citation: J-Rheumatol. ... Cited by 38 - Related articles - Cached - All 3 versions
Z Ortiz, B Shea, ME Suarez-Almazor, D Moher, GA … - Journal of …, 1998 - cat.inist.fr Objective. To assess the efficacy of folic acid and folinic acid in reducing the mucosal and
gastrointestinal(GI) side effects of low dose methotrexate(MTX) in patients with rheumatoid
arthritis(RA). Methods. A systematic review was carried out using the methods ... Cited by 95 - Related articles - All 3 versions
LM Buckley, PM Vacek, SM Cooper - The Journal of rheumatology, 1990 - ncbi.nlm.nih.gov Folinic acid (leucovorin) supplementation has been suggested as a possible means of treating
the short term side effects that occur with low dose methotrexate (MTX). However, it has not been
established whether leucovorin will abrogate the antiarthritic effect of MTX. We entered 20 ... Cited by 38 - Related articles - All 2 versions
